These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 31927768)

  • 21. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.
    Marder KS; Tang MX; Mejia-Santana H; Rosado L; Louis ED; Comella CL; Colcher A; Siderowf AD; Jennings D; Nance MA; Bressman S; Scott WK; Tanner CM; Mickel SF; Andrews HF; Waters C; Fahn S; Ross BM; Cote LJ; Frucht S; Ford B; Alcalay RN; Rezak M; Novak K; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Neils GD; Verbitsky M; Kisselev S; Caccappolo E; Ottman R; Clark LN
    Arch Neurol; 2010 Jun; 67(6):731-8. PubMed ID: 20558392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction and validation of a Parkinson's disease mutation genotyping array for the Parkin gene.
    Clark LN; Haamer E; Mejia-Santana H; Harris J; Lesage S; Durr A; Bs SJ; Hedrich K; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Scott W; Klein C; Brice A; Roomere H; Ottman R; Marder K
    Mov Disord; 2007 May; 22(7):932-7. PubMed ID: 17415800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impulsive-compulsive behaviors in parkin-associated Parkinson disease.
    Morgante F; Fasano A; Ginevrino M; Petrucci S; Ricciardi L; Bove F; Criscuolo C; Moccia M; De Rosa A; Sorbera C; Bentivoglio AR; Barone P; De Michele G; Pellecchia MT; Valente EM
    Neurology; 2016 Oct; 87(14):1436-1441. PubMed ID: 27590295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.
    Alcalay RN; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella CL; Nance MA; Bressman SB; Scott WK; Tanner CM; Mickel SF; Waters CH; Fahn S; Cote LJ; Frucht SJ; Ford B; Rezak M; Novak KE; Friedman JH; Pfeiffer RF; Marsh L; Hiner B; Payami H; Molho E; Factor SA; Nutt JG; Serrano C; Arroyo M; Ottman R; Pauciulo MW; Nichols WC; Clark LN; Marder KS
    JAMA Neurol; 2014 Jan; 71(1):62-7. PubMed ID: 24190026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between obsessive-compulsive symptoms and PARKIN genotype: The CORE-PD study.
    Sharp ME; Caccappolo E; Mejia-Santana H; Tang MX; Rosado L; Orbe Reilly M; Ruiz D; Louis ED; Comella C; Nance M; Bressman S; Scott WK; Tanner C; Waters C; Fahn S; Cote L; Ford B; Rezak M; Novak K; Friedman JH; Pfeiffer R; Payami H; Molho E; Factor SA; Nutt J; Serrano C; Arroyo M; Pauciulo MW; Nichols WC; Clark LN; Alcalay RN; Marder KS
    Mov Disord; 2015 Feb; 30(2):278-83. PubMed ID: 25393808
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicotine increases lifespan and rescues olfactory and motor deficits in a Drosophila model of Parkinson's disease.
    Chambers RP; Call GB; Meyer D; Smith J; Techau JA; Pearman K; Buhlman LM
    Behav Brain Res; 2013 Sep; 253():95-102. PubMed ID: 23871228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous phenotype in a family with compound heterozygous parkin gene mutations.
    Deng H; Le WD; Hunter CB; Ondo WG; Guo Y; Xie WJ; Jankovic J
    Arch Neurol; 2006 Feb; 63(2):273-7. PubMed ID: 16476817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parkin mutation associated parkinsonism and cognitive decline, comparison to early onset Parkinson's disease.
    Benbunan BR; Korczyn AD; Giladi N
    J Neural Transm (Vienna); 2004 Jan; 111(1):47-57. PubMed ID: 14714215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Event-related potential changes due to early-onset Parkinson's disease in parkin (PARK2) gene mutation carriers and non-carriers.
    Uslu A; Ergen M; Demirci H; Lohmann E; Hanagasi H; Demiralp T
    Clin Neurophysiol; 2020 Jul; 131(7):1444-1452. PubMed ID: 32388155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease.
    Poorkaj P; Nutt JG; James D; Gancher S; Bird TD; Steinbart E; Schellenberg GD; Payami H
    Am J Med Genet A; 2004 Aug; 129A(1):44-50. PubMed ID: 15266615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Language Deficits as a Preclinical Window into Parkinson's Disease: Evidence from Asymptomatic Parkin and Dardarin Mutation Carriers.
    García AM; Sedeño L; Trujillo N; Bocanegra Y; Gomez D; Pineda D; Villegas A; Muñoz E; Arias W; Ibáñez A
    J Int Neuropsychol Soc; 2017 Feb; 23(2):150-158. PubMed ID: 28205494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Olfaction in
    Wang Y; Wu JJ; Liu FT; Chen K; Chen C; Luo SS; Wang YX; Li DK; Guan RY; Yang YJ; An Y; Wang J; Sun YM
    Brain Behav; 2017 May; 7(5):e00680. PubMed ID: 28523222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel compound heterozygous of PARKIN causes early-onset Parkinson's disease.
    Yu LH; Peng GP; Yuan Y; Liu XY; Ji F; Li Y; He FP; Luo BY; Ke Q
    Neurosci Lett; 2021 Jan; 744():135597. PubMed ID: 33373675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How much phenotypic variation can be attributed to parkin genotype?
    Lohmann E; Periquet M; Bonifati V; Wood NW; De Michele G; Bonnet AM; Fraix V; Broussolle E; Horstink MW; Vidailhet M; Verpillat P; Gasser T; Nicholl D; Teive H; Raskin S; Rascol O; Destée A; Ruberg M; Gasparini F; Meco G; Agid Y; Durr A; Brice A; ;
    Ann Neurol; 2003 Aug; 54(2):176-85. PubMed ID: 12891670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease.
    Alcalay RN; Mejia-Santana H; Mirelman A; Saunders-Pullman R; Raymond D; Palmese C; Caccappolo E; Ozelius L; Orr-Urtreger A; Clark L; Giladi N; Bressman S; Marder K;
    Parkinsonism Relat Disord; 2015 Feb; 21(2):106-10. PubMed ID: 25434972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutation analysis of parkin and PINK1 genes in early-onset Parkinson's disease in China.
    Zhang BR; Hu ZX; Yin XZ; Cai M; Zhao GH; Liu ZR; Luo W
    Neurosci Lett; 2010 Jun; 477(1):19-22. PubMed ID: 20399249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonmotor symptoms in Parkin gene-related parkinsonism.
    Kägi G; Klein C; Wood NW; Schneider SA; Pramstaller PP; Tadic V; Quinn NP; van de Warrenburg BP; Bhatia KP
    Mov Disord; 2010 Jul; 25(9):1279-84. PubMed ID: 20629119
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A family with Parkinson disease, essential tremor, bell palsy, and parkin mutations.
    Deng H; Le WD; Hunter CB; Mejia N; Xie WJ; Jankovic J
    Arch Neurol; 2007 Mar; 64(3):421-4. PubMed ID: 17353387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.